Atlas Venture Associates Ix is an investment fund managing more than $631 million ran by Jeff Fagnan. There are currently 8 companies in Mr. Fagnan’s portfolio. The largest investments include Skillz and Intellia Therapeutics Inc, together worth $554 million.
As of 4th February 2021, Atlas Venture Associates Ix’s top holding is 23,284,403 shares of Skillz currently worth over $466 million and making up 73.8% of the portfolio value.
Relative to the number of outstanding shares of Skillz, Atlas Venture Associates Ix owns less than approximately 0.1% of the company.
In addition, the fund holds 1,615,321 shares of Intellia Therapeutics Inc worth $87.9 million, whose value grew 258.2% in the past six months.
The third-largest holding is Surface Oncology Inc worth $27.2 million and the next is Spero Therapeutics Inc worth $26.7 million, with 1,376,968 shares owned.
Currently, Atlas Venture Associates Ix's portfolio is worth at least $631 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Atlas Venture Associates Ix office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Jeff Fagnan serves as the Member at Atlas Venture Associates Ix.
In the most recent 13F filing, Atlas Venture Associates Ix revealed that it had opened a new position in Skillz and bought 23,284,403 shares worth $466 million.
The two most similar investment funds to Atlas Venture Associates Ix are Anderson Hoagland & Co and Usadvisors Wealth Management. They manage $631 million and $631 million respectively.
Atlas Venture Associates Ix’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Communication Services — making up 73.8% of
the total portfolio value.
The fund focuses on investments in the United States as
62.5% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
25% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $16.6 billion.
These positions were updated on February 11th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Skillz Inc. |
Opened
23,284,403
|
$465,688,000 | 73.80% |
| Intellia Therapeutics Inc |
Opened
1,615,321
|
$87,873,000 | 13.93% |
| Surface Oncology Inc |
Opened
2,945,453
|
$27,216,000 | 4.31% |
| Spero Therapeutics Inc |
Opened
1,376,968
|
$26,700,000 | 4.23% |
| Cogent Biosciences, Inc. |
Opened
916,196
|
$10,289,000 | 1.63% |
| Snap Inc |
Opened
150,160
|
$7,519,000 | 1.19% |
| Synlogic Inc |
Opened
2,651,963
|
$5,728,000 | 0.91% |
| 0 |
No change
0
|
$0 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 8 holdings | |||